| Primary |
| Contraception |
54.1% |
| Off Label Use |
13.5% |
| Depression |
4.1% |
| Menstrual Cycle Management |
3.3% |
| Abdominal Discomfort |
2.5% |
| Menstruation Irregular |
2.5% |
| Hypersensitivity |
2.0% |
| Hypertension |
2.0% |
| Oral Contraception |
2.0% |
| Sleep Disorder |
2.0% |
| Anxiety |
1.6% |
| Dysmenorrhoea |
1.6% |
| Hormone Level Abnormal |
1.2% |
| Hormone Therapy |
1.2% |
| Menorrhagia |
1.2% |
| Menstrual Discomfort |
1.2% |
| Migraine |
1.2% |
| Antiinflammatory Therapy |
0.8% |
| Asthma |
0.8% |
| Diabetes Mellitus |
0.8% |
|
| Unintended Pregnancy |
23.0% |
| Drug Ineffective |
18.8% |
| Metrorrhagia |
16.2% |
| Product Quality Issue |
15.7% |
| Vaginal Haemorrhage |
3.1% |
| Abnormal Withdrawal Bleeding |
2.6% |
| Abortion Spontaneous |
2.6% |
| Menorrhagia |
2.6% |
| Muscle Spasms |
2.1% |
| Vomiting |
2.1% |
| Pregnancy On Oral Contraceptive |
1.6% |
| Abdominal Distension |
1.0% |
| Abdominal Pain |
1.0% |
| Abortion Threatened |
1.0% |
| Asthenia |
1.0% |
| Drug Ineffective For Unapproved Indication |
1.0% |
| Inappropriate Schedule Of Drug Administration |
1.0% |
| Joint Injury |
1.0% |
| Menstrual Disorder |
1.0% |
| Menstruation Irregular |
1.0% |
|
| Secondary |
| Contraception |
32.4% |
| Off Label Use |
20.7% |
| Dysmenorrhoea |
9.6% |
| Migraine |
4.3% |
| Gastritis |
3.7% |
| Hiv Infection |
3.7% |
| Nasopharyngitis |
3.7% |
| Menstrual Cycle Management |
3.2% |
| Menstruation Irregular |
2.7% |
| Amenorrhoea |
2.1% |
| Hormone Level Abnormal |
2.1% |
| Menorrhagia |
2.1% |
| Hormone Therapy |
1.6% |
| Menstrual Discomfort |
1.6% |
| Aplastic Anaemia |
1.1% |
| Depression |
1.1% |
| Diabetes Mellitus |
1.1% |
| Endometriosis |
1.1% |
| Fibrocystic Breast Disease |
1.1% |
| Hypertension |
1.1% |
|
| Drug Ineffective |
17.8% |
| Product Quality Issue |
17.8% |
| Unintended Pregnancy |
13.7% |
| Abnormal Withdrawal Bleeding |
6.8% |
| Metrorrhagia |
6.8% |
| Menstrual Disorder |
5.5% |
| Inappropriate Schedule Of Drug Administration |
4.1% |
| Asthenia |
2.7% |
| Ataxia |
2.7% |
| Diabetic Ketoacidosis |
2.7% |
| Drug Ineffective For Unapproved Indication |
2.7% |
| Menorrhagia |
2.7% |
| Menstruation Irregular |
2.7% |
| Vomiting |
2.7% |
| Abdominal Distension |
1.4% |
| Acne |
1.4% |
| Acne Cystic |
1.4% |
| Amenorrhoea |
1.4% |
| Anxiety |
1.4% |
| Cerebral Haemorrhage |
1.4% |
|
| Concomitant |
| Febrile Neutropenia |
12.9% |
| In Vitro Fertilisation |
12.9% |
| Asthma |
11.3% |
| Prevention Of Premature Ovulation |
9.7% |
| Ovulation Induction |
6.5% |
| Cardiac Failure |
4.8% |
| Dysmenorrhoea |
4.8% |
| Menometrorrhagia |
4.8% |
| Ovarian Hyperstimulation Syndrome |
4.8% |
| Anxiety Disorder |
3.2% |
| Blood Luteinising Hormone |
3.2% |
| Gastritis |
3.2% |
| Oedema |
3.2% |
| Prophylaxis |
3.2% |
| Pruritus |
3.2% |
| Abdominal Pain Lower |
1.6% |
| Acute Myeloid Leukaemia |
1.6% |
| Arthralgia |
1.6% |
| Constipation |
1.6% |
| Cytarabine Syndrome |
1.6% |
|
| Deep Vein Thrombosis |
7.7% |
| Drug Exposure During Pregnancy |
7.7% |
| Metrorrhagia |
7.7% |
| Ovarian Hyperstimulation Syndrome |
7.7% |
| Pregnancy |
7.7% |
| Restlessness |
7.7% |
| Threatened Labour |
7.7% |
| Abortion Missed |
3.8% |
| Alanine Aminotransferase Increased |
3.8% |
| Anaemia |
3.8% |
| Drug Exposure Before Pregnancy |
3.8% |
| Dyspnoea |
3.8% |
| Ectopic Pregnancy |
3.8% |
| Extrasystoles |
3.8% |
| Ovarian Enlargement |
3.8% |
| Rhabdomyolysis |
3.8% |
| Tendon Rupture |
3.8% |
| Tubulointerstitial Nephritis |
3.8% |
| Urine Potassium Decreased |
3.8% |
|
